Recombinant PDCD1 (Sintilimab Biosimilar) antibody

Catalog No. ABIN7488193

This anti-PDCD1 (Sintilimab Biosimilar) antibody is a Mammalian Cells Monoclonal antibody detecting PDCD1 (Sintilimab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant PDCD1 (Sintilimab Biosimilar) antibody (ABIN7488193)

Target: PDCD1 (Sintilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This PDCD1 (Sintilimab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-PDCD1 (Sintilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Sintilimab Biosimilar - Anti-PDCD1, PD1, CD279 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for PDCD1 (Sintilimab Biosimilar)

Target: PDCD1 (Sintilimab Biosimilar)

Target Type: Biosimilar

Background: IBI-308
Sintilimab biosimilar is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. It is an IgG4 kappa immunoglobulin.

CAS-No: 2072873-06-2